US$ 26.12
abbvie glp-1 receptor agonist glp-1_analogs [TUSOM abbvie glp-1 AbbVie Enters Obesity
Description
Combination therapy with DPP-4 inhibitors and insulin in patients with type 2 diabetes mellitus: What is the evidence

Once-weekly exenatide in youth with type 2 diabetes

Egypt J

GIP(3-30)NH 2 demonstrated an inhibition of the GIP-potentiated glucose-stimulated insulin secretion by 82%

Retatrutide is an investigational triple-receptor agonist, also developed by Eli Lilly

Hypersecretion of gastric inhibitory polypeptide following oral glucose in diabetes mellitus
